Machine learning can help predict whether people newly diagnosed with MS will experience disability worsening that occurs ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
A new study from Norway found a 42% lower risk of developing MS among women with greater dietary vitamin D intake, ...
Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and multiple sclerosis (MS) have both ...
Abundance of severe gum disease like periodontitis may worsen disability for people with multiple sclerosis (MS), a chronic autoimmune disease of the body ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Abundance of severe gum disease -- periodontitis -- may worsen disability for people with multiple sclerosis (MS), a chronic autoimmune disease of the central nervous system.
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...
Please provide your email address to receive an email when new articles are posted on . High intake of oily and lean fish reduced the risk for confirmed worsening disability in adults with MS. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback